CRIS
Permanent URI for this communityhttps://investigadores.udd.cl/handle/123456789/1
Browse
7 results
Search Results
Now showing 1 - 7 of 7
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Potential use of n-3 PUFAs to prevent oxidative stress-derived ototoxicity caused by platinum-based chemotherapy(2020); Scopus© Citations 4 1 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer(2020)37Scopus© Citations 899 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Mesenchymal stem cell therapy for doxorubicin cardiomyopathy: hopes and fears(2015); ; Helio C Salgado11Scopus© Citations 23 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countries(2018)1Scopus© Citations 46 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Triple-negative breast cancer: the reality in Chile and in Latin America(2019)Scopus© Citations 15 1 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Barriers in Latin America for the management of locally advanced breast cancer(2019)1Scopus© Citations 48 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study(2019)Scopus© Citations 731 3